<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00385723</url>
  </required_header>
  <id_info>
    <org_study_id>AG0087</org_study_id>
    <secondary_id>2006H0054</secondary_id>
    <secondary_id>R01AG029562</secondary_id>
    <nct_id>NCT00385723</nct_id>
  </id_info>
  <brief_title>Fish Oil (Omega 3), Immune Function, and Mood</brief_title>
  <official_title>Omega-3 Dietary Supplementation, Immune Function, and Mood</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ohio State University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Aging (NIA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Ohio State University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is designed to examine the effects of fish oil on immune function and mood.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The beneficial effects of fish oil (or eating fish more frequently) include reductions in
      triglycerides, blood pressure, and heart rate, as well as increases in HDL cholesterol, the
      &quot;good&quot; type of cholesterol. In addition, certain aspects of immune function also appear to
      show favorable responses to fish oil supplementation, and some studies suggest that fish oil
      helps to improve mood and decrease depression.

      This study is designed to examine how supplementation with omega-3 polyunsaturated fatty
      acids (key fish oil components) affects aspects of your immune response, and your mood;
      because some research suggests that people who eat more fish may do better during stressful
      times, the study will also examine how fish oil affects your immune response to stress,
      certain stress hormone responses, and your psychological response to stress.

      For detailed information about the study, please visit our website at
      http://www.stressandhealth.org
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2006</start_date>
  <completion_date type="Actual">February 2011</completion_date>
  <primary_completion_date type="Actual">February 2011</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Serum ln(TNF-a)</measure>
    <time_frame>Baseline &amp; 4 months</time_frame>
    <description>log-transformed serum Tumor Necrosis Factor-alpha (TNF-alpha)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Serum ln(IL-6)</measure>
    <time_frame>Baseline &amp; 4 months</time_frame>
    <description>log-transformed serum Interleukin-6 (IL-6)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>ln(CES-D)</measure>
    <time_frame>Baseline &amp; 4 months</time_frame>
    <description>log-transformed Center for Epidemiologic Studies Depression Scale (CES-D) score The CES-D is a self-report scale designed to measure current symptoms of depression rated on a four-point likert scale.
Scores range from 0-60, with higher scores indicating a higher frequency of depressive symptoms.</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">138</enrollment>
  <condition>Inflammation</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1.25 g/d</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>2.496 g/d</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Omega 3 (Fish Oil) Supplementation</intervention_name>
    <description>1.25 g or 2.496 g daily for 4 months</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>matching placebo capsule daily for 4 months</description>
    <arm_group_label>3</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Recruiting men and women ages 40-88 from the Greater Columbus Ohio area. Participation
        involves taking capsules for 4 months and completing 6 appointments (for a total of 19.5
        hours) at Ohio State.

        Inclusion Criteria:

          -  Healthy men and women

          -  NOT currently taking any sort of fish oil or omega 3 supplement

        Exclusion Criteria:

          -  Use of blood pressure medicines, cholesterol-lowering drugs, steroids, or
             antidepressants

          -  Certain lifestyle habits such as smoking or exercising vigorously for 2 or more hours
             a week may also exclude applicants from participating
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>88 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Janice K. Kiecolt-Glaser</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ohio State University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Ohio State University</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.stressandhealth.org</url>
    <description>Please click here to visit our website if you would like to read more about the study or apply to participate.</description>
  </link>
  <results_reference>
    <citation>Kiecolt-Glaser JK, Belury MA, Andridge R, Malarkey WB, Hwang BS, Glaser R. Omega-3 supplementation lowers inflammation in healthy middle-aged and older adults: a randomized controlled trial. Brain Behav Immun. 2012 Aug;26(6):988-95. doi: 10.1016/j.bbi.2012.05.011. Epub 2012 May 26.</citation>
    <PMID>22640930</PMID>
  </results_reference>
  <results_reference>
    <citation>Kiecolt-Glaser JK, Epel ES, Belury MA, Andridge R, Lin J, Glaser R, Malarkey WB, Hwang BS, Blackburn E. Omega-3 fatty acids, oxidative stress, and leukocyte telomere length: A randomized controlled trial. Brain Behav Immun. 2013 Feb;28:16-24. doi: 10.1016/j.bbi.2012.09.004. Epub 2012 Sep 23.</citation>
    <PMID>23010452</PMID>
  </results_reference>
  <verification_date>November 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 10, 2006</study_first_submitted>
  <study_first_submitted_qc>October 10, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 11, 2006</study_first_posted>
  <results_first_submitted>August 28, 2012</results_first_submitted>
  <results_first_submitted_qc>October 9, 2012</results_first_submitted_qc>
  <results_first_posted type="Estimate">November 8, 2012</results_first_posted>
  <last_update_submitted>November 13, 2012</last_update_submitted>
  <last_update_submitted_qc>November 13, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 20, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ohio State University</investigator_affiliation>
    <investigator_full_name>Janice Kiecolt-Glaser</investigator_full_name>
    <investigator_title>Professor of Psychiatry and Psychology</investigator_title>
  </responsible_party>
  <keyword>affect</keyword>
  <keyword>inflammation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Inflammation</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Data collection for this double-blind placebo-controlled four month randomized clinical trial began in September, 2006 and ended in February, 2011. Ohio State University campus and community print and web-based announcements were used for recruitment.</recruitment_details>
      <pre_assignment_details>We used participants' ability to follow the regimen as a criterion for study entry. Participants received a 7-day supply of placebo capsules (single blind) at the subsequent in-person screening session, and those who had taken less than 80% of the capsules a week later were dropped before randomization.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Placebo</title>
          <description>Placebo : matching placebo capsule daily for 4 months</description>
        </group>
        <group group_id="P2">
          <title>1.25 g/d n-3</title>
          <description>Omega 3 (Fish Oil) Supplementation : 1.25 g daily for 4 months</description>
        </group>
        <group group_id="P3">
          <title>2.5 g/d n-3</title>
          <description>Omega 3 (Fish Oil) Supplementation : 2.496 g daily for 4 months</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="46"/>
                <participants group_id="P2" count="46"/>
                <participants group_id="P3" count="46"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="44"/>
                <participants group_id="P2" count="45"/>
                <participants group_id="P3" count="44"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Placebo</title>
          <description>Placebo : matching placebo capsule daily for 4 months</description>
        </group>
        <group group_id="B2">
          <title>1.25 g/d n-3</title>
          <description>Omega 3 (Fish Oil) Supplementation : 1.25 g daily for 4 months</description>
        </group>
        <group group_id="B3">
          <title>2.5 g/d n-3</title>
          <description>Omega 3 (Fish Oil) Supplementation : 2.496 g daily for 4 months</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="46"/>
            <count group_id="B2" value="46"/>
            <count group_id="B3" value="46"/>
            <count group_id="B4" value="138"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="51.1" spread="8.6"/>
                    <measurement group_id="B2" value="51.1" spread="8.0"/>
                    <measurement group_id="B3" value="51.0" spread="6.7"/>
                    <measurement group_id="B4" value="51.0" spread="7.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="36"/>
                    <measurement group_id="B2" value="28"/>
                    <measurement group_id="B3" value="29"/>
                    <measurement group_id="B4" value="93"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="17"/>
                    <measurement group_id="B4" value="45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="33"/>
                    <measurement group_id="B2" value="39"/>
                    <measurement group_id="B3" value="37"/>
                    <measurement group_id="B4" value="109"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="8"/>
                    <measurement group_id="B4" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sagittal abdominal diameter</title>
          <units>cm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="22.8" spread="3.2"/>
                    <measurement group_id="B2" value="23.9" spread="3.4"/>
                    <measurement group_id="B3" value="22.9" spread="2.9"/>
                    <measurement group_id="B4" value="22.8" spread="3.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>CES-D</title>
          <description>Center for Epidemiologic Studies Depression Scale (CES-D) score The CES-D is a self-report scale designed to measure current symptoms of depression rated on a four-point likert scale.
Scores range from 0-60, with higher scores indicating a higher frequency of depressive symptoms.</description>
          <units>scores on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5" lower_limit="3" upper_limit="9"/>
                    <measurement group_id="B2" value="5" lower_limit="2" upper_limit="11"/>
                    <measurement group_id="B3" value="6" lower_limit="2" upper_limit="10"/>
                    <measurement group_id="B4" value="5" lower_limit="2" upper_limit="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Serum ln(TNF-a)</title>
        <description>log-transformed serum Tumor Necrosis Factor-alpha (TNF-alpha)</description>
        <time_frame>Baseline &amp; 4 months</time_frame>
        <population>intention to treat</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo : matching placebo capsule daily for 4 months</description>
          </group>
          <group group_id="O2">
            <title>1.25 g/d n-3</title>
            <description>Omega 3 (Fish Oil) Supplementation : 1.25 g daily for 4 months</description>
          </group>
          <group group_id="O3">
            <title>2.5 g/d n-3</title>
            <description>Omega 3 (Fish Oil) Supplementation : 2.496 g daily for 4 months</description>
          </group>
        </group_list>
        <measure>
          <title>Serum ln(TNF-a)</title>
          <description>log-transformed serum Tumor Necrosis Factor-alpha (TNF-alpha)</description>
          <population>intention to treat</population>
          <units>pg/ml (raw TNF-a)</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="46"/>
                <count group_id="O2" value="46"/>
                <count group_id="O3" value="46"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline (visit 1)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.66" spread="0.25"/>
                    <measurement group_id="O2" value="0.74" spread="0.25"/>
                    <measurement group_id="O3" value="0.71" spread="0.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change, Visit 1 to 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.11" spread="0.030"/>
                    <measurement group_id="O2" value="0.002" spread="0.028"/>
                    <measurement group_id="O3" value="-0.024" spread="0.029"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Comparison was made on change from baseline to 4 months</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.03</p_value>
            <p_value_desc>Bonferroni-adjusted to account for multiple testing.</p_value_desc>
            <method>Mixed Models Analysis</method>
            <param_type>Difference in change from baseline</param_type>
            <param_value>-0.11</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.04</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.19</ci_lower_limit>
            <ci_upper_limit>-0.028</ci_upper_limit>
            <estimate_desc>1.25 g/d minus placebo</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Comparison was made on the change from baseline to 4 months.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.004</p_value>
            <p_value_desc>Bonferroni-adjusted to account for multiple testing.</p_value_desc>
            <method>Mixed Models Analysis</method>
            <param_type>Difference in change from baseline</param_type>
            <param_value>-0.13</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.04</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.22</ci_lower_limit>
            <ci_upper_limit>-0.052</ci_upper_limit>
            <estimate_desc>2.5 g/d minus placebo</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Serum ln(IL-6)</title>
        <description>log-transformed serum Interleukin-6 (IL-6)</description>
        <time_frame>Baseline &amp; 4 months</time_frame>
        <population>intention to treat</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo : matching placebo capsule daily for 4 months</description>
          </group>
          <group group_id="O2">
            <title>1.25 g/d n-3</title>
            <description>Omega 3 (Fish Oil) Supplementation : 1.25 g daily for 4 months</description>
          </group>
          <group group_id="O3">
            <title>2.5 g/d n-3</title>
            <description>Omega 3 (Fish Oil) Supplementation : 2.496 g daily for 4 months</description>
          </group>
        </group_list>
        <measure>
          <title>Serum ln(IL-6)</title>
          <description>log-transformed serum Interleukin-6 (IL-6)</description>
          <population>intention to treat</population>
          <units>pg/ml (raw IL-6)</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="46"/>
                <count group_id="O2" value="46"/>
                <count group_id="O3" value="46"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline (visit 1)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.91" spread="0.60"/>
                    <measurement group_id="O2" value="1.02" spread="0.60"/>
                    <measurement group_id="O3" value="0.85" spread="0.60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change, Visit 1 to 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.31" spread="0.077"/>
                    <measurement group_id="O2" value="-0.106" spread="0.070"/>
                    <measurement group_id="O3" value="-0.123" spread="0.074"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Comparison was made on change from baseline to 4 months.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.0003</p_value>
            <p_value_desc>Bonferroni-adjusted to account for multiple testing.</p_value_desc>
            <method>Mixed Models Analysis</method>
            <param_type>Difference in change from baseline</param_type>
            <param_value>-0.41</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.10</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.62</ci_lower_limit>
            <ci_upper_limit>-0.21</ci_upper_limit>
            <estimate_desc>1.25 g/d minus placebo</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Comparison was made on the change from baseline to 4 months.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.0002</p_value>
            <p_value_desc>Bonferroni-adjusted to account for multiple testing.</p_value_desc>
            <method>Mixed Models Analysis</method>
            <param_type>Difference in change from baseline</param_type>
            <param_value>-0.43</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.11</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.64</ci_lower_limit>
            <ci_upper_limit>-0.22</ci_upper_limit>
            <estimate_desc>2.5 g/d minus placebo</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>ln(CES-D)</title>
        <description>log-transformed Center for Epidemiologic Studies Depression Scale (CES-D) score The CES-D is a self-report scale designed to measure current symptoms of depression rated on a four-point likert scale.
Scores range from 0-60, with higher scores indicating a higher frequency of depressive symptoms.</description>
        <time_frame>Baseline &amp; 4 months</time_frame>
        <population>intention to treat</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo : matching placebo capsule daily for 4 months</description>
          </group>
          <group group_id="O2">
            <title>1.25 g/d n-3</title>
            <description>Omega 3 (Fish Oil) Supplementation : 1.25 g daily for 4 months</description>
          </group>
          <group group_id="O3">
            <title>2.5 g/d n-3</title>
            <description>Omega 3 (Fish Oil) Supplementation : 2.496 g daily for 4 months</description>
          </group>
        </group_list>
        <measure>
          <title>ln(CES-D)</title>
          <description>log-transformed Center for Epidemiologic Studies Depression Scale (CES-D) score The CES-D is a self-report scale designed to measure current symptoms of depression rated on a four-point likert scale.
Scores range from 0-60, with higher scores indicating a higher frequency of depressive symptoms.</description>
          <population>intention to treat</population>
          <units>scores on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="46"/>
                <count group_id="O2" value="46"/>
                <count group_id="O3" value="46"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline (visit 1)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.5" spread="0.17"/>
                    <measurement group_id="O2" value="1.5" spread="0.17"/>
                    <measurement group_id="O3" value="1.6" spread="0.17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change, visit 1 to 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.056" spread="0.15"/>
                    <measurement group_id="O2" value="-0.29" spread="0.15"/>
                    <measurement group_id="O3" value="-0.26" spread="0.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Comparison was made on the change from baseline to 4 months.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.80</p_value>
            <p_value_desc>Bonferroni-adjusted to account for multiple testing.</p_value_desc>
            <method>Mixed Models Analysis</method>
            <param_type>Difference in change from baseline</param_type>
            <param_value>-0.23</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.21</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.64</ci_lower_limit>
            <ci_upper_limit>0.18</ci_upper_limit>
            <estimate_desc>1.25 g/d minus placebo</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Comparison was made on the change from baseline to 4 months.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>1.0</p_value>
            <p_value_desc>Bonferroni-adjusted to account for multiple testing.</p_value_desc>
            <method>Mixed Models Analysis</method>
            <param_type>Difference in change from baseline</param_type>
            <param_value>-0.20</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.21</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.61</ci_lower_limit>
            <ci_upper_limit>0.21</ci_upper_limit>
            <estimate_desc>2.5 g/d minus placebo</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>4 months</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Placebo</title>
          <description>Placebo : matching placebo capsule daily for 4 months</description>
        </group>
        <group group_id="E2">
          <title>1.25 g/d n-3</title>
          <description>Omega 3 (Fish Oil) Supplementation : 1.25 g daily for 4 months</description>
        </group>
        <group group_id="E3">
          <title>2.5 g/d n-3</title>
          <description>Omega 3 (Fish Oil) Supplementation : 2.496 g daily for 4 months</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="46"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>1</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="42" subjects_at_risk="46"/>
                <counts group_id="E2" subjects_affected="38" subjects_at_risk="46"/>
                <counts group_id="E3" subjects_affected="40" subjects_at_risk="46"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Swollen glands</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="46"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="46"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="46"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="46"/>
                <counts group_id="E3" events="8" subjects_affected="8" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Stomach pain</sub_title>
                <counts group_id="E1" events="12" subjects_affected="12" subjects_at_risk="46"/>
                <counts group_id="E2" events="13" subjects_affected="13" subjects_at_risk="46"/>
                <counts group_id="E3" events="14" subjects_affected="14" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Diarrhea</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="46"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="46"/>
                <counts group_id="E3" events="12" subjects_affected="12" subjects_at_risk="46"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Ear ache</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="46"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="46"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Sore throat</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="46"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="46"/>
                <counts group_id="E3" events="8" subjects_affected="8" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Stuffy nose</sub_title>
                <counts group_id="E1" events="18" subjects_affected="18" subjects_at_risk="46"/>
                <counts group_id="E2" events="20" subjects_affected="20" subjects_at_risk="46"/>
                <counts group_id="E3" events="23" subjects_affected="23" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Wheeze</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="46"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="46"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Dry cough</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="46"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="46"/>
                <counts group_id="E3" events="6" subjects_affected="6" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Wet cough</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="46"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="46"/>
                <counts group_id="E3" events="6" subjects_affected="6" subjects_at_risk="46"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Janice K. Kiecolt-Glaser</name_or_title>
      <organization>Institute for Behavioral Medicine Research, Ohio State University College of Medicine, OH, USA</organization>
      <phone>+1 614 293 3499</phone>
      <email>Janice.Kiecolt-Glaser@osumc.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

